{"id":"NCT01272947","sponsor":"Novartis","briefTitle":"Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied Four Times Daily in Subjects With Acute Blunt Trauma Injuries","officialTitle":"A Randomized, Double-blind, Multi-center, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Diclofenac Sodium Topical Gel (DSG) 1% Applied Four Times Daily in Subjects With Acute Blunt Soft Tissue Injuries/Contusions of the Limbs","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-01","primaryCompletion":"2011-07","completion":"2011-07","firstPosted":"2011-01-10","resultsPosted":"2013-01-10","lastUpdate":"2013-01-10"},"enrollment":204,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Acute Blunt Soft Tissue Injuries/Contusions"],"interventions":[{"type":"DRUG","name":"Diclofenac sodium","otherNames":[]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"Diclofenac sodium topical gel 1%","type":"EXPERIMENTAL"},{"label":"placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the efficacy of DSG 1% compared with placebo applied four times a day in subjects with acute blunt soft tissue injuries/contusions of the limbs","primaryOutcome":{"measure":"Pain on Movement","timeFrame":"VAS Score at 24 hours","effectByArm":[{"arm":"Diclofenac Sodium Topical Gel 1%","deltaMin":33.1,"sd":21.4},{"arm":"Placebo","deltaMin":65.4,"sd":16.9}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":1},"locations":{"siteCount":6,"countries":["Germany"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":104},"commonTop":["Infections and Infestations","Musculoskeletal and connective tissue disorders"]}}